These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11680022)

  • 21. Current controversies in ductal carcinoma in situ of the breast: summary from the Lynn Sage Breast Cancer Symposium.
    Silverstein MJ
    J Am Coll Surg; 2003 Jul; 197(1):115-8. PubMed ID: 12831931
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tumorectomy plus irradiation in ductal in-situ carcinoma].
    Dunst J
    Strahlenther Onkol; 1996 Jun; 172(6):344-5. PubMed ID: 8677509
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast conservation therapy in the management of invasive and in situ carcinoma.
    Masko GB; Triedman SA; Brotman RL; Webber BM; Yu A
    R I Med; 1995 Sep; 78(9):246-9. PubMed ID: 7579719
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard?].
    Barillot I; Cutuli B; Arnould L
    Cancer Radiother; 2004 Feb; 8(1):9-20. PubMed ID: 15093196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of local recurrence after breast-conserving therapy in young patients.
    Baltoyiannis G; Roukos DH; Fatouros M
    Radiother Oncol; 2008 Feb; 86(2):286-7; author reply 287-8. PubMed ID: 17963905
    [No Abstract]   [Full Text] [Related]  

  • 26. [Radiotherapy for breast cancer: which strategy in 2012?].
    Cutuli B
    Cancer Radiother; 2012 Sep; 16(5-6):493-502. PubMed ID: 22925489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ductal carcinoma in situ (DCIS): can radiotherapy be avoided?].
    Coucke PA; Barthelemy N; Jansen N; Triviere N; Jerusalem G
    Rev Med Liege; 2008 Feb; 63(2):75-81. PubMed ID: 18372544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Margin status in ductal carcinoma in situ of the breast].
    Vincens E; Alves K; Lauratet B; Cohen S; Bakenga J; Trie A; Lefranc JP
    Bull Cancer; 2008 Dec; 95(12):1155-9. PubMed ID: 19091648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgical treatment of carcinoma in situ of the breast].
    Gangi S; Costanzo MP; Furci M; Khansa K; Basile F
    Ann Ital Chir; 1995; 66(1):47-50; discussion 50-1. PubMed ID: 7668482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
    Suh WW; Hillner BE; Pierce LJ; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
    van der Sangen MJ; van de Poll-Franse LV; Roumen RM; Rutten HJ; Coebergh JW; Vreugdenhil G; Voogd AC
    Eur J Surg Oncol; 2006 Feb; 32(1):34-8. PubMed ID: 16305821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
    Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
    Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast-conserving therapy in young women with invasive carcinoma of the breast.
    Borg MF
    Australas Radiol; 2004 Sep; 48(3):376-82. PubMed ID: 15344990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Zammit C; Yelland A; Deutsch G
    Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C; Burke JP; Morrow M; Kell MR
    J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Breast-conserving surgery for ductal carcinoma in situ of the breast].
    Shimada A
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():528-32. PubMed ID: 23350456
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of radiotherapy in breast-conserving therapy].
    Yamauchi C
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():533-7. PubMed ID: 23350457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.